These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 16963845)
1. Use of dorzolamide for patients with X-linked retinoschisis. Apushkin MA; Fishman GA Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845 [TBL] [Abstract][Full Text] [Related]
2. Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis. Apushkin MA; Fishman GA; Janowicz MJ Ophthalmology; 2005 Mar; 112(3):495-501. PubMed ID: 15745780 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Genead MA; Fishman GA; Walia S Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541 [TBL] [Abstract][Full Text] [Related]
4. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Grover S; Apushkin MA; Fishman GA Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110 [TBL] [Abstract][Full Text] [Related]
5. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Fishman GA; Apushkin MA Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269 [TBL] [Abstract][Full Text] [Related]
6. Relation of response to treatment with dorzolamide in X-linked retinoschisis to the mechanism of functional loss in retinoschisin. Walia S; Fishman GA; Molday RS; Dyka FM; Kumar NM; Ehlinger MA; Stone EM Am J Ophthalmol; 2009 Jan; 147(1):111-115.e1. PubMed ID: 18834580 [TBL] [Abstract][Full Text] [Related]
7. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome. Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176 [TBL] [Abstract][Full Text] [Related]
9. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity. Andreuzzi P; Fishman GA; Anderson RJ Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908 [TBL] [Abstract][Full Text] [Related]
10. Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide. Collison FT; Genead MA; Fishman GA; Stone EM Ophthalmic Genet; 2014 Jun; 35(2):125-7. PubMed ID: 23514609 [No Abstract] [Full Text] [Related]
11. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Genead MA; Fishman GA Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798 [TBL] [Abstract][Full Text] [Related]
12. Foveal ganglion cell layer damage in ischemic diabetic maculopathy: correlation of optical coherence tomographic and anatomic changes. Byeon SH; Chu YK; Lee H; Lee SY; Kwon OW Ophthalmology; 2009 Oct; 116(10):1949-59.e8. PubMed ID: 19699533 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis. Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928 [TBL] [Abstract][Full Text] [Related]
14. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema. Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220 [TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa. Chung H; Hwang JU; Kim JG; Yoon YH Retina; 2006 Oct; 26(8):922-7. PubMed ID: 17031294 [TBL] [Abstract][Full Text] [Related]
19. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Giuffre G Am J Ophthalmol; 2006 Oct; 142(4):707; author reply 707-8. PubMed ID: 17011883 [No Abstract] [Full Text] [Related]
20. In vivo imaging reveals novel aspects of retinal disease progression in Rs1h(-/Y) mice but no therapeutic effect of carbonic anhydrase inhibition. Zhour A; Bolz S; Grimm C; Willmann G; Schatz A; Weber BH; Zrenner E; Fischer MD Vet Ophthalmol; 2012 Sep; 15 Suppl 2():123-33. PubMed ID: 22672048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]